Northern Ireland plays its part in COVID-19 vaccine development
People in Northern Ireland have been playing their part in the development of a potential new COVID-19 vaccine as part of a UK-wide trial. The National Institute for Health Research (NIHR)-supported Novavax Phase 3 COVID-19 vaccine trial has achieved its recruitment target of 15,203 volunteers just two months after opening in the UK – including 482 participants from Northern Ireland. This is the first COVID-19 vaccine trial to take place in Northern Ireland and the number recruited surpassed the original target of 350. Recruitment closed on Friday 27 November at its Belfast site, where staff